NICE has announced that the immunotherapy nivolumab will now be made available on the Cancer Drugs Fund for treating locally advanced or metastatic squamous and non-squamous non-small-cell lung cancers after prior chemotherapy.
One of Britain’s biggest privately owned biotech companies is set to secure additional funding which could propel its progress in developing novel immunotherapies.
Handheld instrument identifies cancerous tissue during surgery, providing surgeons with accurate diagnostic information about what tissue to cut or preserve.
Utilizing historical perspective methods, in this article the authors explore how clarity about the ends of engagement can inform the design of engagement efforts and lead to better outcomes; and present several lessons for improving stakeholder-engaged research.
This article reviews progress made in the creation of a transplantable artificial ovary and discusses future trends for its development.
Discover more about idiopathic thrombocytopenic purpura in this case report from Immunotherapy.